Pain
Conference Coverage
IBD quality initiative slashes ED utilization
A quality initiative led to sharp drops in emergency department visits, hospitalizations, and opioid use for Crohn’s and ulcerative colitis...
News from the FDA/CDC
CDC: Opioid prescribing and use rates down since 2010
From the Journals
Cannabis for sleep: Short-term benefit, long-term disruption?
“This suggests that while cannabis may improve overall sleep, it’s also possible that there is a tolerance that develops with either very frequent...
From the Journals
IBD: Inpatient opioids linked with outpatient use
Alternative analgesics should be considered for patients with inflammatory bowel disease.
Feature
FDA advisers set high bar for new opioids
Two days of FDA discussion over three new opioids seeking U.S. approval highlighted the barriers these drugs now face.
News from the FDA/CDC
FDA committee rejects oxycodegol, new opioid designed for less abuse
A novel opioid molecule designed to have less abuse potential with slower CNS entry received a unanimous FDA committee turn down.
News
FDA okays ubrogepant for acute migraine treatment
ACHIEVE I and ACHIEVE II demonstrate efficacy.
From the Journals
Well-tolerated topical capsaicin formulation reduces knee OA pain
ATLANTA – A new vehicle formulation improves tolerability of capsaicin treatment.
Conference Coverage
In addiction, abusive partners can wreak havoc
SAN DIEGO – Strategies of abusive partners include sabotaging and discrediting their partners’ attempts at recovery, Dr. Carole Warshaw said.
Conference Coverage
Addiction specialists: Cannabis policies should go up in smoke
SAN DIEGO –
Feature
Survey: Cancer-related pain, opioid use up since 2018
Almost half of patients with cancer did not use anything to manage related symptoms, according to an ASCO poll.